Skip to main content

Currently Skimming:

Appendix C: Biographical Sketches of Workshop Presenters
Pages 79-102

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 79...
... He is undertaking doctoral research with a focus on barriers and facilitators of telemedicine adoption in sub-Saharan Africa. Celia Alpuche Aranda, M.D., Ph.D., is a physician specializing in pediatric infectious diseases.
From page 80...
... She is the director of the Instituto Nacional de Salud Pública Center for Infectious Diseases Research (2013–present)
From page 81...
... Regional Office for Africa in Brazzaville, Congo. She coordinates WHO's work in the African Region to introduce new vaccines and increase uptake of underused vaccines and chairs the vaccines pillar for its COVID-19 pandemic response Incident Management Support Team in the region.
From page 82...
... Maria Elena Bottazzi, Ph.D., is the associate dean of the National School of Tropical Medicine, a professor of pediatrics, and the co-director of the Texas Children's Center for Vaccine Development at the Baylor College of Medicine in Houston, Texas. She is an internationally recognized vaccine scientist and global health advocate with more than two decades of contributions in science, biotechnology, and vaccine development tackling neglected and emerging infectious diseases.
From page 83...
... . During his service in WHO, he was involved in revising and implementing the the International Health Regulations, WHO's response to the 2009–2010 H1N1 influenza pandemic and 2014–2016 Ebola outbreak, and institutional aspects of WHO reform.
From page 84...
... He is the editor in chief of Influenza and Other Respiratory Viruses and an associate editor of Emerging Infectious Diseases. His work is supported by a number of major grants from funding bodies in Hong Kong and the United States.
From page 85...
... He led several field missions on the Middle Eastern respiratory syndrome in Saudi Arabia and Korea, Ebola in West Africa in 2014, and H5N1 in Egypt and was WHO's technical lead on negotiations related to the Pandemic Influenza
From page 86...
... She is actively involved in research and training in global health, reproductive health, sexually transmitted infection/ HIV, human papillomavirus, and medical informatics and has expertise in public health interventions, infectious diseases, and implementation science.
From page 87...
... She has an M.Sc. in public health from the London School of Hygiene & Tropical Medicine and an M.A.
From page 88...
... supporting vaccine research and immunization program and health emergencies. Richard Hatchett, M.D., is the chief executive officer of the Coalition for Epidemic Preparedness Innovations, a partnership of public, private, philanthropic, and civil organizations that supports developing vaccines against high-priority public health threats and technology platforms to allow rapidly creating vaccines against emerging infectious diseases, such as COVID-19.
From page 89...
... and international public health partners. From 2014 to 2019, she served as the director general of the Center for Infectious Disease Research of the Korea Centers for Disease Control and led various international activities, including the WHO–Korea Joint Mission on the Middle Eastern respiratory syndrome outbreak in 2015 and the WHO International Health Regulations Joint External Evaluation on national public health emergency response capacity in 2017.
From page 90...
... She also represents CIHR and the government of Canada at various national and international forums related to infectious diseases. In this capacity, she serves as a chair of GloPID-R, a global consortium of funders in pandemic preparedness and emergency response research.
From page 91...
... Dr. Kremer is the recipient of the 2019 Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel, awarded jointly with Abhijit Banerjee and Esther Duflo "for their experimental approach to alleviating global poverty." Heidi Larson, Ph.D., is an anthropologist and the director of the Vaccine Confidence Project; a professor of anthropology, risk, and decision science in the Department of Infectious Disease Epidemiology at the London School of Hygiene & Tropical Medicine; a clinical professor at the Institute of Health Metrics and Evaluation at the University of Washington, Seattle; and a guest professor at the University of Antwerp, Belgium, and National University of Singapore.
From page 92...
... Tapiwa Mukwashi, M.Sc., is the supply chain director at VillageReach. With 15 years of private-sector and international development experience across sub-Saharan Africa, he plays a central role in guiding the organization's programs in strengthening, cost benchmarking, and integrating supply chains that provide health products to community health workers.
From page 93...
... He is an adjunct professor at the Emory University School of Public Health. He serves on several international advisory boards, including the Coalition for Epidemic Preparedness Innovations and the International AIDS Vaccine Initiative.
From page 94...
... He served on many technical committees of the Netherlands Medical Research Council, more recently on the National Academies' Committee on the Evaluation of Strengthening Human Resources for Health Capacity in the Republic of Rwanda Under the President's Emergency Plan for AIDS Relief (PEPFAR) , and continues to advise international agencies and governments in fields of global health, such as infectious diseases, research and innovation, health workforce systems, pharmaceuticals/vaccines and medical technology, and health financing and economics.
From page 95...
... , the World Health Organization's Regional Office for the Americas. He has more than 20 years of experience on international supply chain management, procurement, and logistics of essential health technologies for prevention, treatment and emergency response, such as vaccines, and essential medicines for communicable and noncommunicable diseases. He leads the team managing the procurement strategy and operations for PAHO's Revolving Funds for Access to Vaccines and Strategic Fund for Essential Medicines.
From page 96...
... He completed medical training at the National University of Ireland, Galway, an M.A. in public health at University College Dublin, and specialist training in communicable disease control at the Health Protection Agency in London and the European Program for Intervention Epidemiology Training.
From page 97...
... In 2015–2016, he was the chair of the National Academy of Medicine's Commission on a Global Health Risk Framework for the Future, which published the influential report The Neglected Dimension of Global Security: A Framework to Counter Infectious Disease Threats (2016)
From page 98...
... She was the chief of the Emerging Respiratory Viruses Section of the Laboratory of Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID)
From page 99...
... She is an internationally recognized leader in the field of emerging respiratory viruses. She is an elected fellow of the American Academy of Microbiology and the Infectious Diseases Society of America and a member of the American Society of Microbiology, the American Society for Virology, and the Australasian Virology Society.
From page 100...
... She has held leadership roles in the industry association IFPMA Influenza Vaccine Supply Taskforce for the past 10 years, as the coordinator of the Scientific, Production, and Regulatory group for 6 years, and the chair of the group since February 2018.
From page 101...
... His research group examines a number of aspects of influenza virus biology, with a particular focus on interactions at the human–animal interface. He is the director of the World Health Organization's Collaborating Centre for Studies on the Ecology of Influenza in Animals and Birds and the principal investigator of National Institute of Allergy and Infectious Diseases–funded St.
From page 102...
... Global Influenza Program in its headquarters in Geneva, Switzerland, since November 2012. In this role, he provides leadership and coordinates global activities on influenza surveillance, virus monitoring, detection of emerging novel viruses, risk assessment, and evidence for policies, vaccines, and pandemic preparedness, including pandemic influenza vaccine response.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.